Insulin Glargine Mouse mAb from ELK Biotechnology Read more ›
Insulin Glargine Mouse mAb is a research-use antibody from ELK Biotechnology for studying Insulin Glargine in ELISA workflows. Specifications and supporting documents below should be reviewed when planning the experiment.
Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes.
| Collaborator | ELK Biotechnology |
| Partner model | EM1116 |
| Target | Insulin Glargine |
| Research areas | Antibody Research |
| Reactivity | Insulin Glargine:C |
| Applications | ELISA |
| Conjugation | Unconjugated |
| Dilution range | ELISA 1:2,000-10,000 |
| Host | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Immunogen | Insulin Glargine |
| Concentration | 1mg/mL |
| Assay type | Antibody validation/application |
| Species | WB | IHC | IF | ELISA | IP | FCM | ChIP |
|---|---|---|---|---|---|---|---|
| Insulin Glargine |
| Species | Dilution | Notes |
|---|---|---|
| Insulin Glargine | ELISA 1:2 | — |
Collaborator meets ABMIUM quality standards and overall product performance standards have been met.
Quality management certification.
For research applications. Not for diagnostic use.
No customer reviews yet.
